Macroaxis: Personalized Investing
Simple Personalized Investing

QLT RVX ONC CNJ ETFs Aggressive Music and Video Drugs 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for ISA

Isotechnika quote and profile

 
 Companies |  Insiders  | Dashboard  
     
0.04
  
STOCK
0.0050  Macroaxis: 14.29 Up   14.29%  
May 25 2013 

Diversification Suggestion

Use Isotechnika to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.
Analyze Isotechnika Pharma Trend or Check current 30 days Isotechnika correlation with market (S&P 500)
1 Month Beta 6.51  
Highest Price:  
Lowest Price:  
0.04  
0.03  
April 29 2013 
April 25 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Isotechnika will likely underperform.
Isotechnika Pharma Inc Large BetaIsotechnika Pharma Beta Legend
ISA Canada Toronto #B613Z26CA
Isotechnika Pharma Inc
Healthcare
Biotechnology
Benchmark S&P 500
http://www.isotechnika.com
Contact Number: 780. 487. 1600
Currency: CAD - Canadian Dollar
Traded on Toronto Stock Exchange
    
Current Valuation7.57 M
Shares Outstanding192.87 M
Revenue6.13 M
Cash and Equivalents184 K
 thisGreen ISA ISA.TO agains markets  14.29 % Macroaxis: change 14.29 Moved Up  
 
 Canada Canada   0.07 % Macroaxis: 0.07 Moved Up  
 
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Isotechnika Leadership

Robert Foster President CEO, Director
MPharm, (Pharm) CEO and President and Director
Peter Wijngaard Independent Chairman of the Board, Ph.D
Dennis CA CFO and Secretary

Isotechnika Price and Market Media

The median price of Isotechnika for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 0.04 with a coefficient of variation of 11.6. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.04, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
Isotechnika         SP 500
Price Growth (%)
 

Isotechnika Summary

Isotechnika Pharma Inc [ISA] is traded on Toronto Stock Exchange in Canada. It is located in Edmonton, AB TE W and employs 26 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 5.79 M. Isotechnika Pharma Inc operates under Healthcare sector and is part of Biotechnology industry. This company has 192.87 M outstanding shares.
Isotechnika Pharma Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of immunomodulating therapeutics. more
Past Market
Over 30
Days
9
Out Of
100
 
Chance of
Less
Than
%
 
Follow Isotechnika with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Isotechnika to your reader
 

Isotechnika Research Report

Isotechnika vs. QLT

Correlation analysis and fundamentals comparison between Isotechnika Pharma and QLT Inc

Isotechnika Executives

Dennis CA CFO and Secretary
Dennis Bourgeault CFO, Corporate Secretary
RAC Aspeslet COO
Launa Aspeslet COO, Ph.D

Isotechnika Directors

Woo Choi Director
Daniel Park Director
Heung-Joon Yang Director, Ph.D
Prakash Gowd Director, MBA
Donald Wyatt Independent Director

Isotechnika Management

Robert Huizinga VP of Clinical Affairs
MSc(Epi), NNC VP of Clinical Affairs
Derrick Freitag Chief Scientific Officer, Ph.D

Isotechnika Fundamentals

Earnings Per Share vs Return On Equity
Profit Margin vs Current Ratio
Earnings Per Share vs One Year High
Number of Employees vs Current Ratio

Isotechnika vs Competition

Isotechnika vs. QLT Inc
Isotechnika vs. Resverlogix Corp
Isotechnika vs. Oncolytics Biotech Inc
Isotechnika vs. Cangene Corp
Isotechnika vs. Medicago Inc
Isotechnika vs. ProMetic Life Sciences Inc
Isotechnika vs. Transition Therapeutics Inc
Isotechnika vs. Burcon Nutrascience Corporation
Isotechnika vs. Tekmira Pharmaceuticals Corporation
Isotechnika vs. Helix Biopharma Corp

Isotechnika May 25 2013 Opportunity Range

Information Ratio0.1532
Maximum Drawdown58.33
Potential Upside33.33

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium